| the chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity–a tale of conflict and conundrum M Müller, S Carter, MJ Hofer, IL Campbell Neuropathology and applied neurobiology 36 (5), 368-387, 2010 | 317 | 2010 |
| Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review VX Han, S Patel, HF Jones, TC Nielsen, SS Mohammad, MJ Hofer, ... Translational psychiatry 11 (1), 71, 2021 | 228 | 2021 |
| CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central … M Müller, SL Carter, MJ Hofer, P Manders, DR Getts, MT Getts, ... The Journal of Immunology 179 (5), 2774-2786, 2007 | 217 | 2007 |
| Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with … C Wacher, M Müller, MJ Hofer, DR Getts, R Zabaras, SS Ousman, ... Journal of virology 81 (2), 860-871, 2007 | 174 | 2007 |
| Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis A Quintana, M Muller, RF Frausto, R Ramos, DR Getts, E Sanz, MJ Hofer, ... The Journal of Immunology 183 (3), 2079-2088, 2009 | 142 | 2009 |
| Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration JPK Ip, AL Nocon, MJ Hofer, SL Lim, M Müller, IL Campbell Journal of neuroinflammation 8, 1-16, 2011 | 120 | 2011 |
| Microglia responses to interleukin‐6 and type I interferons in neuroinflammatory disease PK West, B Viengkhou, IL Campbell, MJ Hofer Glia 67 (10), 1821-1841, 2019 | 82 | 2019 |
| CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia J Zimmermann, M Krauthausen, MJ Hofer, MT Heneka, IL Campbell, ... PloS one 8 (2), e57307, 2013 | 73 | 2013 |
| Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages DR Getts, RL Terry, MT Getts, M Müller, S Rana, C Deffrasnes, ... Journal of neuroinflammation 9, 1-8, 2012 | 72 | 2012 |
| Deterministic assembly of complex bacterial communities in guts of germ-free cockroaches A Mikaelyan, CL Thompson, MJ Hofer, A Brune Applied and Environmental Microbiology 82 (4), 1256-1263, 2016 | 68 | 2016 |
| IFIT2 is an effector protein of type I IFN–mediated amplification of lipopolysaccharide (LPS)-induced TNF-α secretion and LPS-induced endotoxin shock A Siegfried, S Berchtold, B Manncke, E Deuschle, J Reber, T Ott, M Weber, ... The Journal of Immunology 191 (7), 3913-3921, 2013 | 67 | 2013 |
| Low avidity of human serum antibodies for Borna disease virus antigens questions their diagnostic value U Allmang, M Hofer, S Herzog, K Bechter, P Staeheli Molecular psychiatry 6 (3), 329-333, 2001 | 60 | 2001 |
| Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7 N Vachharajani, T Joeris, M Luu, S Hartmann, S Pautz, E Jenike, ... Oncotarget 8 (31), 50447, 2017 | 58 | 2017 |
| Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10 B Almolda, C de Labra, I Barrera, A Gruart, JM Delgado-Garcia, ... Brain, behavior, and immunity 45, 80-97, 2015 | 58 | 2015 |
| Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus MJ Hofer, W Li, P Manders, R Terry, SL Lim, NJC King, IL Campbell Journal of virology 86 (12), 6932-6946, 2012 | 58 | 2012 |
| Borna disease virus in human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders M Czygan, W Hallensleben, M Hofer, S Pollak, C Sauder, T Bilzer, ... The Journal of infectious diseases 180 (5), 1695-1699, 1999 | 53 | 1999 |
| Type I interferon in neurological disease—the devil from within MJ Hofer, IL Campbell Cytokine & growth factor reviews 24 (3), 257-267, 2013 | 52 | 2013 |
| Transgenic models for cytokine-induced neurological disease IL Campbell, MJ Hofer, A Pagenstecher Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1802 (10 …, 2010 | 49 | 2010 |
| The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-γ in microglia of the central nervous system is determined by the myeloid transcription factor PU. 1 SL Ellis, V Gysbers, PM Manders, W Li, MJ Hofer, M Müller, IL Campbell The Journal of Immunology 185 (3), 1864-1877, 2010 | 49 | 2010 |
| PLX5622 reduces disease severity in lethal CNS infection by off-target inhibition of peripheral inflammatory monocyte production AG Spiteri, D Ni, ZL Ling, L Macia, IL Campbell, MJ Hofer, NJC King Frontiers in Immunology 13, 851556, 2022 | 42 | 2022 |
